Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement to 30 September 2010

17 Nov 2010 07:00

RNS Number : 3009W
British Smaller Companies VCT2 Plc
17 November 2010
 



BRITISH SMALLER COMPANIES VCT2 PLC ("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2010

 

The Company presents its interim management statement for the quarter ended 30 September 2010. This constitutes the Company's second interim management statement for the financial year ending 31 December 2010, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfm.co.uk.

 

The unaudited net asset value per Ordinary share as at 30 September 2010 was 66.2p (30 June 2010: 70.1p). The 3.9p reduction in the quarter is primarily due to 2.0p per share final dividend paid 30 September 2010 along with a downward movement in the valuation of the unquoted portfolio.

 

The total return at 30 September 2010, calculated by reference to the net asset value per share and the cumulative dividends paid, is 92.2p per share compared to 94.1p at 30 June 2010.

 

The number of Ordinary shares in issue at 30 September 2010 was 17,837,519. There were no shares purchased or issued by the Company during the quarter.

 

Pursuant to the resolution passed at the General Meeting on 18 October 2010 the name of the Company was changed from British Smaller Technology Companies VCT2 plc to British Smaller Companies VCT2 plc with effect from 22 October 2010. A further resolution was passed at this meeting (as set out in the RNS announcement on 20 October 2010) for the Company to make market purchases of its own shares.

 

Net assets at 30 September 2010 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

5,260

44.5

Quoted investments at bid price

905

7.7

Gilt investments

4,042

34.2

Total financial assets at fair value

10,207

86.4

Cash and cash equivalents

1,329

11.3

Other net current assets (liabilities)

275

2.3

Net assets

11,811

100.0

 

 

The ten largest investments by valuation at 30 September 2010 were as follows:

 

Current cost

£000

Value

£000

% of net assets

Primal Pictures Limited

897

1,184

10.0

Digital Healthcare Limited

3,072

1,156

9.8

Immunobiology Limited

1,032

1,002

8.5

Bluebell Telecom Group

500

500

4.2

Waterfall Services Limited

250

494

4.2

Pressure Technologies plc

300

350

3.0

Patsystems plc

317

311

2.6

Harvey Jones Limited

389

273

2.3

Deep-Secure Ltd

500

250

2.1

RMS Group Holdings Limited

210

140

1.2

Top 10 investments

7,467

5,660

47.9

Other 11 investments

2,521

505

4.3

Gilt investments

3,974

4,042

34.2

Total

13,962

10,207

86.4

 

Quoted investments are carried at bid price at 30 September 2010, discounted for liquidity as appropriate. Unquoted investment are carried at fair value as at 30 September 2010 as determined by the directors.

 

During September 2010 the Company invested £500,000 into the newly formed Bluebell Telecom Group, based in Newcastle-Upon-Tyne, a business seeking to consolidate activities in the telecoms service sector.

 

Shortly after the period end the Company invested £267k as part of a £3m funding syndicate into medical technology business, Sirigen Group Limited.

 

During the three months ended 30 September 2010 the following significant investment disposals took place (all companies are unquoted except where otherwise indicated):

 

Partial Disposals

Name of company:

Sale proceeds

 

£000

Original

cost

 

£000

Carrying value at

31 Dec 2009

 

£000

Primal Pictures Limited

69

22

69

RMS Group Holdings Limited

182

171

138

DxS Limited

165

-

-

416

193

207

 

 

Performance

 

In this period the Company has seen its total return, calculated by reference to the net asset value plus cumulative dividend paid, decrease by 1.9p to 92.2p per share, cumulative dividends representing 26.0p per share.

 

The net asset value currently comprises 45% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

 

The discount of the share price to the net asset value per share has reduced to around 15% as a result of the introduction of the share buyback policy in October 2010.

 

Outlook 

 

Whilst significant uncertainty still exists, this period has also seen continuing signs of economic recovery benefiting a number of the portfolio businesses, with good realisation opportunities now available for quality businesses.

 

The number of new investment opportunities has increased, with more management teams seeking to expand and vendors prepared to sell, which your Board believes will translate into increasing investment opportunities over the short and medium term. This Company is well placed to take advantage of these investment opportunities as well as continuing to support its existing investments. To take full advantage of this market opportunity the board is seeking to increase the investment capacity of the Company via a linked offer together with the British Smaller Companies VCT plc over the coming months.

 

17 November 2010

 

For further information please contact:

 

David Hall YFM Private Equity Tel: 0161 832 7603

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGBWGUPUGMQ
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.